Status:
UNKNOWN
Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluation
Lead Sponsor:
Assiut University
Conditions:
Alopecia Areata
Eligibility:
All Genders
12+ years
Phase:
PHASE4
Brief Summary
Alopecia areata is the most frequent cause of inflammation-induced hair loss with prevalence from 0.1 to 0.2%. It has no age nor sex predilection . Clinically, alopecia areata presents as a well-circ...
Detailed Description
Histologically, lesional biopsies of alopecia areata demonstrate a peri\_follicullare and intra\_folliculare mononuclear cell infiltrate around anagen phase hair follicles .The infiltrate consists mos...
Eligibility Criteria
Inclusion
- Age \>12 years.
- Both sexes will be included.
- Newly diagnosed cases.
Exclusion
- Children \< 12 years.
- Pregnancy and lactation.
- Patients with active scalp infection.
- Patients with cold sensitivity (regarding the first group).
- Any newly onset medical systemic illness.
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03473600
Start Date
November 1 2018
End Date
September 1 2019
Last Update
March 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medicine
Asyut, Egypt, 71111